141 related articles for article (PubMed ID: 16404347)
41. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
[TBL] [Abstract][Full Text] [Related]
42. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
43. Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug.
Xu H; Wang Z; Donaldson JC; Yao H; Zhou S; Kelson AB; Ma W; Weber KT; Laborde E; Cheng M; Sambucetti L; Keck JG
Anticancer Res; 2009 Oct; 29(10):3845-55. PubMed ID: 19846918
[TBL] [Abstract][Full Text] [Related]
44. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice.
Jagetia GC; Baliga MS; Venkatesh P; Ulloor JN; Mantena SK; Genebriera J; Mathuram V
J Pharm Pharmacol; 2005 Sep; 57(9):1213-9. PubMed ID: 16105243
[TBL] [Abstract][Full Text] [Related]
46. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities.
Bartzatt R; Cirillo SL; Cirillo JD; Donigan L
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193
[TBL] [Abstract][Full Text] [Related]
47. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
48. Anticancer activity of an essential oil from Cymbopogon flexuosus.
Sharma PR; Mondhe DM; Muthiah S; Pal HC; Shahi AK; Saxena AK; Qazi GN
Chem Biol Interact; 2009 May; 179(2-3):160-8. PubMed ID: 19121295
[TBL] [Abstract][Full Text] [Related]
49. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
50. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological activity of mustard derivatives of thymine.
Hadj-Bouazza A; Teste K; Colombeau L; Chaleix V; Zerrouki R; Kraemer M; Sainte Catherine O
Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):439-48. PubMed ID: 18569783
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine.
Bielawski K; Bielawska A; Poplawska B
Arch Pharm (Weinheim); 2009 Aug; 342(8):484-90. PubMed ID: 19565602
[TBL] [Abstract][Full Text] [Related]
53. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
54. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
55. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells.
Pors K; Paniwnyk Z; Ruparelia KC; Teesdale-Spittle PH; Hartley JA; Kelland LR; Patterson LH
J Med Chem; 2004 Mar; 47(7):1856-9. PubMed ID: 15027879
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
Sanyal U; Bhattacharya S; Sadhu U; Dutta S; Das H; Ghosh M
Cancer Lett; 1993 Jun; 70(1-2):1-6. PubMed ID: 8330289
[TBL] [Abstract][Full Text] [Related]
58. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of antitumor efficacy and toxicity of novel 6-nitro-2-(3-chloropropyl)-1H-benz[de]isoquinoline-1,3-dione in vivo in mouse.
Mukherjee A; Dutta S; Sanyal U
J Cancer Res Ther; 2013; 9(3):442-6. PubMed ID: 24125980
[TBL] [Abstract][Full Text] [Related]
60. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents.
Scutaru AM; Wenzel M; Scheffler H; Wolber G; Gust R
Bioconjug Chem; 2010 Oct; 21(10):1728-43. PubMed ID: 20849062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]